Anti-Parkinsonian Drugs Today
- 1 September 1984
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 28 (3) , 236-262
- https://doi.org/10.2165/00003495-198428030-00002
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Pharmacologic Effects in Man of a Potent, Long-Acting Dopamine Receptor AgonistScience, 1979
- Effects of (8β)-8-[(Methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in ratsLife Sciences, 1979
- Experiences with L-deprenyl in ParkinsonismJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- L-deprenyl treatment of on-off phenomena in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- The possible mechanisms of action of (-)deprenyl in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- Four‐year treatment of patients with parkinsonism using amantadine alone or with levodopaAnnals of Neurology, 1978
- Anticholinergic and membrane activities of amantadine in neuromuscular transmissionNature, 1976
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975
- ABNORMAL INVOLUNTARY MOVEMENTS IN RELATION TO ANTICHOLINERGICS AND LEVODOPA THERAPYActa Neurologica Scandinavica, 1975
- Mechanism of action of amantadine.BMJ, 1971